1
1
1
1
1
1
1
1
1
1
2
2
1
1
1
1
2016
1
Research Institution (9)University (7)Foundation (2)Company (1)Hospital (1)
1 - 9 of 9
Sort by
Clinical Trial
Clinical Trial IDNCT02094118Start Date2016-01-01Completion Date2018-12-01PhasePhase 1/Phase 2Study TypeInterventionalStatusRecruiting
This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to standard-of-care Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.
Clinical Trial
Clinical Trial IDNCT02401555Start Date2013-04-01Completion Date2013-12-01Study TypeObservationalStatusCompleted
The purpose of this study was to evaluate the performance of the Bio-Rad Geenius HIV 1/2 Supplemental Assay, a single-use immunochromatographic assay for the confirmation and differentiation of individual antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV-1 and HIV-2) in fingerstick whole blood, venous whole blood, serum, or plasma samples (EDTA, heparin, and sodium citrate).
Clinical Trial
Clinical Trial IDNCT01541319Start Date2012-07-01Completion Date2016-08-01Study TypeObservationalStatusCompleted
A large multicenter randomized controlled trial of approximately 1700 critically ill patients' status post complex cardiac surgery with sternotomy, called the Red Cell Storage Duration Study (RECESS), is currently ongoing. In the RECESS trial, study groups are randomized to either RBCs of less than or equal to 10 days storage time or to greater than or equal to 21 days. The primary outcome of RECESS is a change in multiple organ dysfunction score. Secondary outcomes in RECESS include all caus…
Clinical Trial
Clinical Trial IDNCT01555060Start Date2012-03-01Completion Date2013-06-01PhasePhase 2Study TypeInterventionalStatusCompleted
The purpose of this study is to investigate the effect of daily iron supplements after blood donation on time to recovery of hemoglobin and iron stores. The study will also determine whether the effect of iron supplements on time to recovery is different in men and women, in older vs. younger donors (
Clinical Trial
Clinical Trial IDNCT01094197Start Date2010-03-01Completion Date2011-11-01Study TypeObservationalStatusWithdrawn
Individuals who experience traumatic injury often require blood transfusion. In some individuals who receive blood after an injury, white blood cells from a person who donated blood may remain in the body for years, a condition known as microchimerism. This study is designed to examine a group of people who are known to have long-term microchimerism and, through analysis of their blood, determine whether there is evidence that the microchimerism involves blood stem cells that can become any t…
Clinical Trial
Clinical Trial IDNCT00441779Start Date2008-08-01Completion Date2011-10-01Study TypeObservationalStatusTerminated
Blood transfusions are frequently necessary in situations in which there is a large amount of blood loss. In some individuals who receive a blood transfusion, white blood cells from the donor's blood may remain in the body for years, a condition known as microchimerism. This study will evaluate the occurrence of microchimerism among the following three groups of individuals who previously received transfusions: 1) individuals with traumatic injuries; 2) individuals with burn injuries; and 3) …
Clinical Trial
Clinical Trial IDNCT00400192Start Date2006-11-01Completion Date2012-07-01Study TypeObservationalStatusCompleted
Individuals who experience a traumatic injury often have a significant amount of blood loss and may require a blood transfusion. In some individuals who receive a blood transfusion, white blood cells from the donor's blood may remain in the body for years, a condition known as microchimerism. This study will examine the reasons why microchimerism occurs in some blood transfusion recipients and not others.
Clinical Trial
Clinical Trial IDNCT00097006Start Date2004-09-01Completion Date2009-09-01Study TypeObservationalStatusCompleted
To conduct epidemiological, laboratory, and survey research on volunteer blood donors within the United States to ensure the safety and availability of the United States' blood supply.
Clinical Trial
Clinical Trial IDNCT01681420Start Date0001-08-01Completion Date0031-01-01PhaseN/AStudy TypeInterventionalStatusCompleted
Conduct a randomized controlled trial (RCT) to test the hypothesis that offering client-centered HIV counseling and testing (HCT) to blood donor candidates will reduce the risk of HIV contamination in the blood supply and also increase appropriate referrals to preventive and care services to persons in need in São Paulo, Brazil.
We found 9 documents that match your Search
Research Grants: 105
Publications: 567
Patents: 2
Clinical Trials: 9

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in